These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2614090)

  • 21. Effect of aztreonam on throat and stool flora of cancer patients.
    Jones PG; Bodey GP; Swabb EA; Rosenbaum B
    Antimicrob Agents Chemother; 1984 Dec; 26(6):941-3. PubMed ID: 6543108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract.
    Veringa EM; van der Waaij D
    J Antimicrob Chemother; 1984 Dec; 14(6):605-12. PubMed ID: 6520061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.
    van Saene HK; Lemmens SE; van Saene JJ
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():127-34. PubMed ID: 3182454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of biapenem (L-627) on fecal flora in gnotobiotic mice and children].
    Iwata S; Yamamoto K; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T
    Jpn J Antibiot; 1994 Dec; 47(12):1668-84. PubMed ID: 7877249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of erythromycin on the fecal flora of infants less than 1-year old].
    Butel MJ; Boussougant Y
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):591-5. PubMed ID: 3534749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The characteristics of the intestinal Escherichia microflora in patients with acute intestinal infections].
    Ulisko IN; Baturo AP; Romanenko EE; Stepanova MV; Ratiner IuA; Sorkin VM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):17-21. PubMed ID: 8067084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.
    Perrin-Guyomard A; Poul JM; Laurentie M; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):66-78. PubMed ID: 16563587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The aerobic bacterial intestinal flora of various wintering geese species].
    Holländer R
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):394-400. PubMed ID: 7136353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
    Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
    J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients.
    Giuliano M; Pantosti A; Gentile G; Venditti M; Arcese W; Martino P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1709-13. PubMed ID: 2686547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total intestinal decontamination for prevention of infection in bone marrow transplantation.
    Funada H; Teshima H; Hattori K
    Jpn J Clin Oncol; 1983; 13 Suppl 1():111-26. PubMed ID: 6339774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.
    Pecquet S; Andremont A; Tancrède C
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1047-52. PubMed ID: 3729360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antagonism of microbial population of protective flora and its relation to microbiocenosis and nutritional factors].
    Kuvaeva IB; Kuznetsova GG
    Vopr Pitan; 1993; (3):46-50. PubMed ID: 7975434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of long-term preventive use of TMPS on the composition and resistance behavior of aerobic fecal flora].
    Allerberger F; Guggenbichler JP; Ausserer B; Dierich M; Fink FM
    Padiatr Padol; 1987; 22(2):131-7. PubMed ID: 3112699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of intestinal flora in neonates].
    Iseki K
    Hokkaido Igaku Zasshi; 1987 Dec; 62(6):895-906. PubMed ID: 3443432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.
    Pecquet S; Chachaty E; Tancrède C; Andremont A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):548-52. PubMed ID: 2039207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of oral ciprofloxacin on the faecal flora of healthy volunteers.
    Enzensberger R; Shah PM; Knothe H
    Infection; 1985; 13(6):273-5. PubMed ID: 2934338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials.
    Reeves DS
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():89-102. PubMed ID: 3542950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages.
    Terg R; Llano K; Cobas SM; Brotto C; Barrios A; Levi D; Wasen W; Bartellini MA
    J Hepatol; 1998 Sep; 29(3):437-42. PubMed ID: 9764991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.